"Influenza, Human" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.
| Descriptor ID |
D007251
|
| MeSH Number(s) |
C02.782.620.365 C08.730.310
|
| Concept/Terms |
Influenza, Human- Influenza, Human
- Human Influenzas
- Influenzas, Human
- Influenza
- Influenzas
- Human Flu
- Flu, Human
- Human Influenza
- Influenza in Humans
- Influenza in Human
- Grippe
|
Below are MeSH descriptors whose meaning is more general than "Influenza, Human".
Below are MeSH descriptors whose meaning is more specific than "Influenza, Human".
This graph shows the total number of publications written about "Influenza, Human" by people in this website by year, and whether "Influenza, Human" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2000 | 1 | 1 | 2 |
| 2001 | 1 | 0 | 1 |
| 2004 | 3 | 1 | 4 |
| 2005 | 5 | 0 | 5 |
| 2006 | 4 | 2 | 6 |
| 2007 | 2 | 0 | 2 |
| 2008 | 1 | 1 | 2 |
| 2009 | 6 | 0 | 6 |
| 2010 | 5 | 1 | 6 |
| 2011 | 17 | 1 | 18 |
| 2012 | 11 | 2 | 13 |
| 2013 | 14 | 1 | 15 |
| 2014 | 9 | 2 | 11 |
| 2015 | 4 | 1 | 5 |
| 2016 | 3 | 2 | 5 |
| 2017 | 13 | 1 | 14 |
| 2018 | 2 | 1 | 3 |
| 2019 | 5 | 0 | 5 |
| 2020 | 10 | 0 | 10 |
| 2021 | 3 | 0 | 3 |
| 2022 | 8 | 0 | 8 |
| 2023 | 10 | 1 | 11 |
| 2024 | 12 | 0 | 12 |
To return to the timeline,
click here.
Below are the most recent publications written about "Influenza, Human" by people in Profiles.
-
Comparative Effectiveness of Licensed Influenza Vaccines in Preventing Influenza-related Medical Encounters and Hospitalizations in the 2022-2023 Influenza Season Among Adults =65 Years of Age. Clin Infect Dis. 2024 Nov 22; 79(5):1283-1292.
-
Estimated Effectiveness of Influenza Vaccines in Preventing Secondary Infections in Households. JAMA Netw Open. 2024 Nov 04; 7(11):e2446814.
-
Elevated body mass index is not significantly associated with reduced influenza vaccine effectiveness. Sci Rep. 2024 09 13; 14(1):21466.
-
Safety of the Seasonal Influenza Vaccine in 2 Successive Pregnancies. JAMA Netw Open. 2024 Sep 03; 7(9):e2434857.
-
Influenza Vaccine Effectiveness Against Influenza A-Associated Emergency Department, Urgent Care, and Hospitalization Encounters Among US Adults, 2022-2023. J Infect Dis. 2024 Jul 25; 230(1):141-151.
-
Antibody response to sequential vaccination with cell culture, recombinant, or egg-based influenza vaccines among U.S. adults. Hum Vaccin Immunother. 2024 Dec 31; 20(1):2370087.
-
Ipsilateral and contralateral coadministration of influenza and COVID-19 vaccines produce similar antibody responses. EBioMedicine. 2024 May; 103:105103.
-
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged =18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024. MMWR Morb Mortal Wkly Rep. 2024 Mar 28; 73(12):271-276.
-
Recombinant Influenza Vaccine in Adults under 65 Years of Age. Reply. N Engl J Med. 2024 Mar 21; 390(12):1156.
-
Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States. MMWR Morb Mortal Wkly Rep. 2024 Feb 29; 73(8):168-174.